2022-RA-906-ESGO Acid ceramidase (ASAH1) expression is associated with improved progression- and overall survival in high-grade serous ovarian cancer patients

Lars Christian Hanker; Ahemd El-Balat; Thomas Karn; Uwe Holtrich; Bendickt Decker; Jakobus Pfisterer; Heide Gevensleben; Stefan Kommoss

doi:10.1136/ijgc-2022-ESGO.589

Article info

Ovarian cancer

2022-RA-906-ESGO Acid ceramidase (ASAH1) expression is associated with improved progression- and overall survival in high-grade serous ovarian cancer patients

Free

Authors

Lars Christian Hanker Gynecology and Obstetrics, Universityhospital Luebeck, Lübeck, Germany PubMed articles Google scholar articles
Ahemd El-Balat Gynecology and Obstetrics, Spital Ulster, Ulster, Switzerland PubMed articles Google scholar articles
Thomas Karn Gynecology and Obstetrics, Universityhospital Frankfurt am Main, Frankfurt am Main, Germany PubMed articles Google scholar articles
Uwe Holtrich Gynecology and Obstetrics, Universityhospital Frankfurt am Main, Frankfurt am Main, Germany PubMed articles Google scholar articles
Bendickt Decker Gynecology and Obstetrics, Universityhospital Luebeck, Lübeck, Germany PubMed articles Google scholar articles
Jakobus Pfisterer Gynecology, Gynecologic Oncology Center, Kiel, Germany PubMed articles Google scholar articles
Heide Gevensleben Institute of Pathology, University Hospital Bonn, Bonn, Germany PubMed articles Google scholar articles
Stefan Kommoss Gynecology and Obstetrics, Universityhospital Tübingen, Tübingen, Germany PubMed articles Google scholar articles

Citation

Hanker LC, El-Balat A, Karn T, et al

2022-RA-906-ESGO Acid ceramidase (ASAH1) expression is associated with improved progression- and overall survival in high-grade serous ovarian cancer patients

International Journal of Gynecologic Cancer 2022;32:A276.

Publication history

First published October 20, 2022.

Online issue publication

October 27, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password